UK: NICE rejects Johnson and Johnson nasal spray for depression in NHS Medical Dialogues Bureau29 Jan 2020 12:38 PM ISTThe National Institute for Health and Care Excellence (NICE), which determines if a drug is included in Britain's National Healthcare System (NHS),...
Novartis Kymriah wins UK backing after initial lymphoma snub Medical Dialogues Bureau3 Feb 2019 10:00 AM IST"Today's positive announcement regarding access to Kymriah treatment in England and Wales was secured as a result of our close working collaboration...
Novartis Aimovig not cost effective: UK price watchdog Medical Dialogues Bureau11 Jan 2019 9:00 AM ISTNovartis, whose U.K. price for Aimovig is about 5,000 pounds ($6,374) annually but which was offering discounts, is counting on the medicine to be a...
Pfizer, Novartis agree UK price cuts for new breast cancer drugs Ruby Khatun Khatun17 Nov 2017 9:45 AM ISTLONDON: Pfizer and Novartis have agreed to price cuts for their rival breast cancer drugs Ibrance and Kisqali to ensure they can be used routinely...
Britain backs GSK gene therapy for BUBBLE BOY syndrome Ruby Khatun Khatun23 Oct 2017 9:32 AM ISTGlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...